1 |
Highly impaired platelet ultrastructure in two families with novel IKZF5 variants.
6
57
|
Leinoe E...Rossing M
|
32419556 |
2020 |
2 |
Germline mutations in the transcription factor IKZF5 cause thrombocytopenia.
57
6
|
Lentaigne C...Turro E
|
31217188 |
2019 |
3 |
Oral ibuprofen promoted cholestatic liver disease in very low birth weight infants with patent ductus arteriosus.
61
|
Shen X...Zhou P
|
32723673 |
2020 |
4 |
Evidence of acute phase reaction in asymptomatic dogs naturally infected with Babesia canis.
61
|
Milanovic Z...Filipovic MK
|
32473353 |
2020 |
5 |
Clinical Characteristics and Outcome of Children Hospitalized With Scrub Typhus in an Area of Endemicity.
61
|
Wangrangsimakul T...Paris DH
|
30864670 |
2020 |
6 |
Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study.
61
|
Zhang Y...Jin J
|
31938902 |
2020 |
7 |
Cell-free chromatin particles released from dying host cells are global instigators of endotoxin sepsis in mice.
61
|
Mittra I...Raghuram GV
|
32130239 |
2020 |
8 |
Association of Patterns of Mild Traumatic Brain Injury with Neurologic Deterioration: Experience at a Level I Trauma Center.
61
|
Kavi T...Patel UK
|
31723486 |
2019 |
9 |
Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib.
61
|
Stein EM...de Botton S
|
30510081 |
2019 |
10 |
Rituximab-based combination therapy in patients with Waldenström macroglobulinemia: a systematic review and meta-analysis.
61
|
Zheng YH...Chen XQ
|
31043792 |
2019 |
11 |
Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2.
61
|
Macarulla T...Hidalgo M
|
30523758 |
2019 |
12 |
Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical Trial.
61
|
Borges VF...Hamilton E
|
29955792 |
2018 |
13 |
Phase 2 Study of First-line Intensity Modulated Radiation Therapy Followed by Gemcitabine, Dexamethasone, and Cisplatin for High-Risk, Early Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: The GREEN Study.
61
|
Qi F...Dong M
|
30102205 |
2018 |
14 |
Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial.
61
|
Parker CC...Nilsson S
|
28705540 |
2018 |
15 |
Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia.
61
|
Paludo J...Kapoor P
|
28786474 |
2017 |
16 |
Australian taipan (Oxyuranus spp.) envenoming: clinical effects and potential benefits of early antivenom therapy - Australian Snakebite Project (ASP-25).
61
|
Johnston CI...Isbister GK
|
27903075 |
2017 |
17 |
Sunitinib treatment in patients with advanced renal cell cancer: the Brazilian National Cancer Institute (INCA) experience.
61
|
Coelho RC...Herchenhorn D
|
27564279 |
2016 |
18 |
A Phase II Trial of a Histone Deacetylase Inhibitor Panobinostat in Patients With Low-Grade Neuroendocrine Tumors.
61
|
Jin N...LoConte NK
|
27261467 |
2016 |
19 |
A phase II study of bendamustine in combination with rituximab as initial treatment for patients with indolent non-follicular non-Hodgkin lymphoma.
61
|
Luminari S...Baldini L
|
26379040 |
2016 |
20 |
Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study.
61
|
O'Connor OA...Shustov A
|
26101246 |
2015 |
21 |
Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma.
61
|
Mahalingam D...Sarantopoulos J
|
24817603 |
2014 |
22 |
A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors.
61
|
Ghamande S...Goel S
|
24271274 |
2014 |
23 |
Phase II study of pegylated liposomal doxorubicin, low-dose dexamethasone, and lenalidomide in patients with newly diagnosed multiple myeloma.
61
|
Baz RC...Alsina M
|
24030918 |
2014 |
24 |
A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study.
61
|
LoConte NK...Lubner SJ
|
23263993 |
2013 |
25 |
R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study.
61
|
Pappo AS...Baker LH
|
22025149 |
2011 |
26 |
Thrombocytopenic syndromes masquerading as childhood immune thrombocytopenic purpura.
61
|
Bryant N...Watts R
|
21098529 |
2011 |
27 |
Lenalidomide, melphalan, prednisone and thalidomide (RMPT) for relapsed/refractory multiple myeloma.
61
|
Palumbo A...Boccadoro M
|
20376079 |
2010 |
28 |
[Revision of the informed consent form for patients based on investigation of adverse events of mFOLFOX6 regimen].
61
|
Kato T...Boku N
|
19838030 |
2009 |
29 |
A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapy.
61
|
Leary A...Oates J
|
19104814 |
2009 |
30 |
Ixabepilone: a novel microtubule inhibitor for the treatment of locally advanced or metastatic breast cancer.
61
|
Steinberg M
|
18840366 |
2008 |
31 |
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients.
61
|
Zinzani PL...Baccarani M
|
18303033 |
2008 |
32 |
Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancer.
61
|
Loesch D...O'Shaughnessy JA
|
18621615 |
2008 |
33 |
Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma.
61
|
Yuan JN...Whang-Peng J
|
18488159 |
2008 |
34 |
Phase II study of low-grade non-Hodgkin lymphomas with fludarabine and mitoxantrone followed by rituximab consolidation: promising results in marginal zone lymphoma.
61
|
Economopoulos T...Dimopoulos MA
|
18203014 |
2008 |
35 |
[Treatment results of concurrent chemoradiotherapy with CDDP or CDGP plus 5-FU for carcinoma of the oropharynx and hypopharynx].
61
|
Wadasaki K...Hirakawa K
|
17876135 |
2007 |
36 |
Thrombocytopenia related neonatal outcome in preterms.
61
|
Bonifacio L...Mehta R
|
17401266 |
2007 |
37 |
Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer.
61
|
O'Brien ME...Crofts T
|
17135646 |
2006 |
38 |
Vascular lesions in nine Göttingen minipigs with thrombocytopenic purpura syndrome.
61
|
Maratea KA...Stevenson GW
|
16846986 |
2006 |
39 |
A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer.
61
|
Kallab AM...Jillella AP
|
15965277 |
2005 |
40 |
Rituximab for refractory Evans syndrome and other immune-mediated hematologic diseases.
61
|
Mantadakis E...Kalmanti M
|
15495242 |
2004 |
41 |
The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel.
61
|
Hensing TA...Socinski MA
|
12910523 |
2003 |
42 |
[Paclitaxel and carboplatin with or without pirarubicin (THP-ADR) as first line chemotherapy in elderly patients].
61
|
Nagao S...Kudo T
|
12610873 |
2003 |
43 |
Delayed profound thrombocytopenia presenting 7 days after use of abciximab (ReoPro).
61
|
Sharma S...Denny E
|
12000974 |
2002 |
44 |
Paclitaxel and carboplatin as outpatient therapy for stage III and IV epithelial ovarian cancer.
61
|
Balbi GC...Cardone A
|
11677421 |
2001 |
45 |
Preoperative chemoradiotherapy in the treatment of gallbladder cancer.
61
|
de Aretxabala X...Vittini C
|
10075301 |
1999 |
46 |
Anti-platelet antibodies in patients with systemic lupus erythematosus and the primary antiphospholipid antibody syndrome: their relationship with the observed thrombocytopenia.
61
|
Macchi L...Nurden AT
|
9266930 |
1997 |
47 |
Chronic isolated macrothrombocytopenia with autosomal dominant transmission: a morphological and qualitative platelet disorder.
61
|
Fabris F...Girolami A
|
9020372 |
1997 |
48 |
Partial substitution of cisplatin with carboplatin in combination with etoposide in advanced non-small cell lung cancer (NSCLC): a multicentric randomised phase II trial.
61
|
Comella P...Comella G
|
8865128 |
1996 |
49 |
Systemic lupus erythematosus complicated by thrombotic microangiopathy.
61
|
Jain R...Furie R
|
7899875 |
1994 |
50 |
Nephropathia epidemica (hemorrhagic fever with renal syndrome) in children: clinical characteristics.
61
|
Ahlm C...Juto P
|
7909597 |
1994 |